A Phase II Study Of SB-715992 (NSC 727990) In Patients With Locally Advanced, Recurrent Or Metastatic Hepatocellular Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Ispinesib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Nov 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 07 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 17 Aug 2005 New trial record.